Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
EBOS Group Limited ( (AU:EBO) ) has provided an announcement.
EBOS Group Limited has announced the issuance of 6,008 ordinary fully paid securities, which will be quoted on the Australian Securities Exchange (ASX) as of November 18, 2025. This move is part of an employee incentive scheme, reflecting the company’s ongoing efforts to engage and reward its workforce, potentially impacting its operational dynamics and market positioning positively.
The most recent analyst rating on (AU:EBO) stock is a Hold with a A$28.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.
More about EBOS Group Limited
EBOS Group Limited operates in the healthcare and animal care industries, providing a range of products and services including pharmaceuticals, medical equipment, and veterinary supplies. The company focuses on serving the Australasian market, positioning itself as a key player in these sectors.
Average Trading Volume: 140,912
Technical Sentiment Signal: Sell
Current Market Cap: A$5.13B
For an in-depth examination of EBO stock, go to TipRanks’ Overview page.